As of 2024-12-13, the Intrinsic Value of Neola Medical AB (NEOLA.ST) is
-0.67 SEK. This NEOLA.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.64 SEK, the upside of Neola Medical AB is
-125.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.67 SEK
Intrinsic Value
NEOLA.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.67 - -0.67 |
-0.67 |
-125.57% |
| P/E |
(1.83) - (1.84) |
(1.86) |
-170.3% |
| DDM - Stable |
(1.31) - (14.50) |
(7.90) |
-399.4% |
| DDM - Multi |
(1.16) - (10.46) |
(2.12) |
-180.3% |
NEOLA.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
185.20 |
| Beta |
1.06 |
| Outstanding shares (mil) |
70.15 |
| Enterprise Value (mil) |
156.09 |
| Market risk premium |
5.10% |
| Cost of Equity |
8.04% |
| Cost of Debt |
5.00% |
| WACC |
6.00% |